Brexpiprazole pharmacokinetics in CYP2D6 poor metabolizers: Using physiologically‐based pharmacokinetic modeling to optimize time‐to‐effective concentrations (JCP‐21‐Apr‐211‐R2)
2016 ◽
Vol 44
(10)
◽
pp. 1569-1578
◽
2018 ◽
2019 ◽
Vol 8
(9)
◽
pp. 664-675
◽
2020 ◽
Vol 41
(6)
◽
pp. 248-267
◽
2019 ◽
Vol 59
(6)
◽
pp. 880-889
◽